Page last updated: 2024-11-02

oxybutynin and Atrioventricular Nodal Re-Entrant Tachycardia

oxybutynin has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research Excerpts

ExcerptRelevanceReference
" Scopolamine is metabolized primarily in the liver and excreted by the kidneys, so renal and hepatic impairment should be considered when initiating and dosing this medication."1.42An unusual case of nonsustained ventricular tachycardia. ( Brandt, JC; Harman, E; Winchester, D, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandt, JC1
Harman, E1
Winchester, D1

Other Studies

1 other study available for oxybutynin and Atrioventricular Nodal Re-Entrant Tachycardia

ArticleYear
An unusual case of nonsustained ventricular tachycardia.
    Therapeutic advances in cardiovascular disease, 2015, Volume: 9, Issue:3

    Topics: Cholinergic Antagonists; Female; Humans; Middle Aged; Scopolamine; Tachycardia, Ventricular; Transde

2015